Table 1. The regulation of immune checkpoints by hypoxia-associated molecules.
| Hypoxia-associated molecules | Immune checkpoints | Impact on immune checkpoints | References |
|---|---|---|---|
| HIF-1α | PDL1 | Stimulatory | Lequeux et al. (2019) and Zhou et al. (2019) |
| HIF-1α | CTLA4, LAG3 | Stimulatory | Doedens et al. (2013) |
| PKM2, PHD3 | PDL1 | Stimulatory | Palsson-McDermott et al. (2017) |
| CA9 | PDL1 | Stimulatory | Giatromanolaki & Harris (2020) |
| Ado, A2aR, A2bR, cAMP | PD1, CTLA4 | Stimulatory | Hatfield et al. (2015) |
| Ado | PD1 | Stimulatory | Allard et al. (2013) |
| Lactate, GPR81, TAZ, TEAD | PDL1 | Stimulatory | Feng et al. (2017) |
| LDH-A | PDL1 | Stimulatory | Seth et al. (2017) |
| ZEB1 | PDL1 | Stimulatory | Chen et al. (2014) |
| SNAIL | PDL1 | Stimulatory | Noman et al. (2017) |
| ZEB1, SNAIL | CD47 | Stimulatory | Noman et al. (2018) |
| cAMP, PKA | PDL1 | Inhibitory | Feng et al. (2017) |
| miR-200 | PDL1 | Inhibitory | Noman et al. (2017) |